These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8879106)

  • 1. Comparison of the efficacy of replication-defective adenovirus and Nyvac poxvirus as vaccine vectors in mice.
    Gonin P; Oualikene W; Fournier A; Eloit M
    Vaccine; 1996 Aug; 14(11):1083-7. PubMed ID: 8879106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.
    Eloit M; Adam M
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies.
    Monteil M; Le Pottier MF; Ristov AA; Cariolet R; L'Hospitalier R; Klonjkowski B; Eloit M
    Vaccine; 2000 Mar; 18(17):1738-42. PubMed ID: 10699321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal vaccination of pigs against Aujeszky's disease: comparison with inactivated vaccines in pigs with low maternal antibody titres.
    De Leeuw PW; Van Oirschot JT
    Res Vet Sci; 1985 Jul; 39(1):34-8. PubMed ID: 2994188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of protective antibody responses against pseudorabies virus by intranasal vaccination with glycoprotein B in mice.
    Takada A; Kida H
    Arch Virol; 1995; 140(9):1629-35. PubMed ID: 7487494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells.
    Ambriović A; Adam M; Monteil M; Paulin D; Eloit M
    Virology; 1997 Nov; 238(2):327-35. PubMed ID: 9400605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine.
    Eloit M; Gilardi-Hebenstreit P; Toma B; Perricaudet M
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2425-31. PubMed ID: 2172456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal vaccination of pigs against Aujeszky's disease: comparison with one or two doses of attenuated vaccines in pigs with high maternal antibody titres.
    Van Oirschot JT
    Res Vet Sci; 1987 Jan; 42(1):12-6. PubMed ID: 3029845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines.
    Welter J; Taylor J; Tartaglia J; Paoletti E; Stephensen CB
    J Virol; 2000 Jul; 74(14):6358-67. PubMed ID: 10864646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice.
    Fischer T; Planz O; Stitz L; Rziha HJ
    J Virol; 2003 Sep; 77(17):9312-23. PubMed ID: 12915547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
    Mettenleiter TC; Klupp BG; Weiland F; Visser N
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth properties and vaccine efficacy of recombinant pseudorabies virus defective in glycoprotein E and thymidine kinase genes.
    Wu CY; Liao CM; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Jul; 229():58-64. PubMed ID: 27164258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple alternating immunizations with DNA vaccine and replication incompetent adenovirus expressing gB of pseudorabies virus protect animals against lethal virus challenge.
    Kim SJ; Kim HK; Han YW; Aleyas AG; George JA; Yoon HA; Yoo DJ; Kim K; Eo SK
    J Microbiol Biotechnol; 2008 Jul; 18(7):1326-34. PubMed ID: 18667863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the efficacy of a replication-defective adenovirus-vectored vaccine by the addition of oil adjuvants.
    Ganne V; Eloit M; Laval A; Adam M; Trouve G
    Vaccine; 1994 Oct; 12(13):1190-6. PubMed ID: 7839723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
    Arellano PE; Morrison RB; Molitor TW; Thawley DG
    J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of intranasal vaccination with plasmid encoding pseudorabies virus glycoprotein B in mice.
    Takada A; Okazaki K; Kida H
    Jpn J Vet Res; 1999 Aug; 47(1-2):25-33. PubMed ID: 10810559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of pigs with a recombinant porcine adenovirus expressing the gD gene from pseudorabies virus.
    Hammond JM; Jansen ES; Morrissy CJ; van der Heide B; Goff WV; Williamson MM; Hooper PT; Babiuk LA; Tikoo SK; Johnson MA
    Vaccine; 2001 Jun; 19(27):3752-8. PubMed ID: 11395210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.
    Kanesa-thasan N; Smucny JJ; Hoke CH; Marks DH; Konishi E; Kurane I; Tang DB; Vaughn DW; Mason PW; Shope RE
    Vaccine; 2000 Oct; 19(4-5):483-91. PubMed ID: 11027812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
    Gómez CE; Nájera JL; Jiménez EP; Jiménez V; Wagner R; Graf M; Frachette MJ; Liljeström P; Pantaleo G; Esteban M
    Vaccine; 2007 Apr; 25(15):2863-85. PubMed ID: 17113200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
    Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.